Recursion gets FDA approval to begin phase 1 trials of AIdiscovered cancer treatment
Oct 02, 2024
Recursion said it was able to use its AI-enabled drug discovery platform to identify a novel target and move all the way to gaining IND approval in less than 18 months.
https://www.cnbc.com/2024/10/02/recursion-gets-fda-approval-to-begin-phase-1-trials-of-ai-discovered-cancer-treatment-.html
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service